Citation Information :
Vladareanu R, Constantinescu S, Denes M, Chilianu A. Magnesium Sulfate: Fetal Neuroprotective Role in Reducing the Risk of Cerebral Palsy. Donald School J Ultrasound Obstet Gynecol 2013; 7 (1):98-104.
Constantinescu S, Denes M, Chilianu A, Vladareanu R. Magnesium Sulfate: Fetal Neuroprotective Role in Reducing the Risk of Cerebral Palsy. Donald School J Ultrasound Obstet Gynecol 2013;7(1):98-104.
Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 2005;47(8):571-76.
Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359(3): 262-73.
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008;359(9):895-905.
Increasing prevalence of cerebral palsy among very preterm infants: A populationbased study. Pediatrics 2006; 118(6):1621-26.
Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: A systematic review and meta-analysis. Am J Obstet Gynecol 2009;200(6):595-609.
Neuroprotective strategies for the neonatal brain. Anesth Analg 2008;106(6):1670-80.
Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Obstet Gynecol Clin North Am 2011; 38(2):351-66.
Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003;102(3):628-36.
Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial. JAMA 2003;290(20):2669-76.
Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol 2010;202(3):292.e1-9.
Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: A meta-analysis. Obstet Gynecol 2009;114(2 Pt 1):354-64.
Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95(2):263-69.
Magnesium sulphate for fetal neuroprotection. Rev Bras Ginecol Obstet 2011;33(6): 265-70.
The use of antenatal magnesium sulfate for neuroprotection for infants born prematurely. F1000 Med Rep 2010;2:78.
Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009;114(3):650-68.
Magnesium sulfate in severe perinatal asphyxia: A randomized, placebo-controlled trial. Pediatrics 2009;123(5):764-69.
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009(1):CD004661.
Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186(6):1111-18.
The Magpie Trial: A randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 2007;114(3):300-09.
The Magpie Trial: A randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007;114(3):289-99.
Magnesium sulphate given before very-preterm birth to protect infant brain: The randomised controlled PREMAG trial BJOG 2007;114(3):310-18.
Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics 2008;121(1):225-26.
Antenatal magnesium sulfate and neurologic outcome in preterm infants: A systematic review. Obstet Gynecol 2009;113(6):1327-33.
Can magnesium sulphate provide neuroprotection in preterm infants? A literature review. RCSIsmj 2011;4(1): 46-52.
Comittee Opinion No. 455. Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010;115:669.
Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines. The University of Adelaide. 2010.
SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can 2011;33(5):516-29.
Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: A decision-analytic and economic analysis. Am J Obstet Gynecol 2011;205(6):542.e1-7.
